This artice is free to access.
Background: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening.Discussion: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening.Summary: Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives. © 2012 Flitcroft et al.; licensee BioMed Central Ltd.
Flitcroft, K. L., Irwig, L. M., Carter, S. M., Salkeld, G. P., & Gillespie, J. A. (2012). Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option. BMC Gastroenterology, 12. https://doi.org/10.1186/1471-230X-12-183